Shares of Tilray Brands Inc. (TLRY) tumbled 5.24% in pre-market trading on Friday, reversing course after a strong surge during Thursday's regular trading session. The cannabis company's stock is taking a hit despite reporting better-than-expected fiscal first-quarter results earlier on Thursday.

The sharp reversal appears to be driven by two key factors. First, Tilray filed for a mixed shelf offering with the SEC following Thursday's market close. This move allows the company to issue various types of securities, including common stock, preferred stock, debt securities, warrants, and units, up to an unspecified amount. While such filings are common for companies looking to raise capital, they often lead to concerns about potential dilution for existing shareholders.

Second, Atb Capital Markets downgraded Tilray from Sector Perform to Underperform, further pressuring the stock. This analyst action suggests a less optimistic outlook for the company's near-term prospects, despite its recent positive earnings report.

The pre-market decline comes on the heels of Tilray's impressive performance on Thursday, where the stock surged 22.09% to close at $2.10. The company had reported strong fiscal Q1 results, with net revenue of $209.5 million, up 5% year-over-year and surpassing analyst estimates. Tilray also delivered a net income of $1.5 million, compared to a net loss in the same quarter last year.

The stark contrast between Thursday's rally and Friday's pre-market plunge highlights the volatile nature of cannabis stocks and investor sensitivity to potential dilution and analyst opinions. Despite the positive earnings report, the prospect of additional share issuances and the analyst downgrade seem to have overshadowed the company's improved financial performance in the eyes of pre-market traders.